/N e ASN is 1.29 [95% confidence interval (CI) of 1.15 to 1.57] and that East Asians received 20.2% (95% CI of 13.4 to 27.1%) more Neandertal sequence in the second pulse (10) . We note that additional unexplored models may provide a better fit to the data, and refining demographic models of hominin evolution is an important area for future work.
The collection of surviving Neandertal lineages that we identified allows us to search for signatures of adaptive introgression (15, 16) . First, we used introgressed variants that exhibit large allele frequency differences between Europeans and East Asians (F ST > 0.40, P < 0.001 by simulation) (10) to identify four significantly differentiated regions (Fig. 4 and table S10) (10) . Introgressed haplotypes in two of these regions span genes that play important roles in the integumentary system: BNC2 on chromosome 9 and POU2F3 on chromosome 11. BNC2 encodes a zinc finger protein expressed in keratinocytes and other tissues (17) and has been associated with skin pigmentation levels in Europeans (18) . The adaptive haplotype has a frequency of~70% in Europeans and is completely absent in East Asians (Fig. 2B ). POU2F3 is a homeobox transcription factor expressed in the epidermis and mediates keratinocyte proliferation and differentiation (19, 20) . The adaptive haplotype in East Asians has a frequency of~66% and is found at less than 1% frequency in Europeans (Fig. 2B) . No coding introgressed variants were found in BNC2 or POU2F3, although several highly differentiated introgressed variants were located in functional noncoding elements (21) (Fig. 2B) , suggesting that modern humans acquired adaptive regulatory sequences at these loci. We also searched for shared signatures of adaptive introgression between East Asians and Europeans, identifying six distinct regions that have introgressed haplotype frequencies greater than 40% in both populations (Fig. 4 and table S11) (P < 10 −4 by simulation) (10) . One of these regions lies in the type II cluster of keratin genes on 12q13 (table S11), further suggesting that Neandertals provided modern humans with adaptive variation for skin phenotypes. In total, 8 of the 10 candidate introgressed regions overlap protein-coding genes (Fig. 4) .
This study shows that the fragmented remnants of the Neandertal genome carried in the DNA of modern humans can be robustly identified, allowing, in aggregate, substantial amounts of Neandertal sequence to be recovered. In principle, our approach can be used in the absence of an archaic reference sequence, potentially allowing the discovery and characterization of previously unknown hominins that interbred with modern humans (22) (23) (24) . This fossil-free paradigm of sequencing archaic genomes holds considerable promise for revealing insights into hominin evolution, the population genetics characteristics of archaic hominins, how introgression has influenced extant patterns of human genomic diversity, and narrowing the search for genetic changes that endow distinctly human phenotypes. 4 ) secretion from BMMCs induced by treatment with 2NP (3000 ng/ml) is less than that with DNP (30 ng/ml). **P < 0.01, ***P < 0.001; one-way ANOVA. (C) Tumor necrosis factor-a (TNFa), interleukin-6 (IL6), and IL13 are similarly affected at the concentrations of DNP and 2NP indicated in (B). *P < 0.05, **P < 0.01, ***P < 0.001; one-way ANOVA. (D) Release of CCL2, CCL3, and CCL4 is increased after stimulation with 2NP relative to DNP [conditions as in (B)]. **P < 0.01, ***P < 0.001; one-way ANOVA. Data were collected from four to eight individual experiments. Fluorescence intensity in cross section (white dotted line) is shown. Localization was analyzed for more than 40 cells in each condition. Scale bars, 5 mm. *P < 0.05, **P < 0.01, ***P < 0.001; one-way ANOVA. Data are representative of at least three independent experiments. fragment (Fc)] to FceRI with high affinity, with the half-life of IgE bound to FceRI measured in days (5) (9)], presumably affecting the duration of the transmitted signal and subsequent outcome. Whether FceRI functionally distinguishes differences in the affinity of IgE antibody and antigen interactions is not clear. To investigate this, we used two previously described antigens (10): dinitrophenyl-caproate-Fab (DNP, high affinity) and 2-nitrophenyl-caproateFab (2NP, low affinity). These differ in their relative affinities for binding to FceRI-bound DNP-specific IgE by approximately three orders of magnitude. In bone marrow-derived mouse mast cells (BMMCs) (11), FceRI phosphorylation was similar with approximately 100 times as much 2NP (3000 ng/ml) as DNP (30 ng/ml) (fig. S1A) ; the kinetics of FceRI phosphorylation were unaltered at these concentrations ( fig. S1B) . However, cellular responses differed as 2NP elicited less than 20% of the DNP-induced degranulation response (Fig. 1A) at 3000 ng/ml and 30 ng/ml, respectively, and showed reduced leukotriene B4 (Fig. 1B ) and cytokine production (Fig. 1C ) but enhanced chemokine production (Fig. 1D) . DNP-and 2NP-induced responses required the presence of DNP-specific IgE ( fig. S2, A and B) , and 2NP treatment had no effect on responses initiated through ovalbumin (OVA)-specific IgE ( fig. S2, C and D) .
To explore the differences in DNP-and 2NP-induced FceRI clustering, we used total internal reflection fluorescence (TIRF) microscopy to study DNP-specific IgE-bearing mast cells after their contact with either a DNP-or 2NP-imbedded planar supported lipid bilayer, while maintaining equal receptor phosphorylation and differences in mast cell degranulation ( fig. S3, A and B) . Exposure to DNP resulted in highly mobile receptor clusters that moved from the cell periphery toward the cell center to form a synapse-like localization as described for the T cell receptor (12, 13) (movie S1). In contrast, treatment with 2NP revealed slower movement of receptor clusters and a diffuse distribution with a loosely organized synapse-like structure at the cell center (movie S2). Analysis of receptor cluster movement with time ( Fig. 2A) revealed greater numbers of receptor clusters at the periphery in 2NP-treated cells. The total number of clusters formed at any given time was greater upon DNP treatment (Fig. 2B) , but the area occupied by these clusters was larger after 2NP treatment (Fig. 2C) . The relative mobility of receptor clusters in cells treated with 2NP was on average one-third that of clusters formed by DNP treatment (Fig. 2D) . Phosphotyrosine (a hallmark of intracellular signaling) was localized with both DNP-and 2NP-formed receptor clusters, although stronger colocalization was evident after 2NP treatment (Fig. 2E ). These findings demonstrate that the FceRI clusters induced by DNP or 2NP differ spatiotemporally.
We explored whether differences in the spatiotemporal behavior of receptor clustering by DNP or 2NP were translated into changes in FceRIgenerated intracellular signals. Analysis of the phosphorylation of FceRIg at Tyr 47 (Y47) showed increased phosphorylation at this site (Fig. 3A) after cell treatment with 2NP, relative to DNP, and the increased phosphorylation was not dependent on Syk, Fyn, or Lyn; however, Lyn deficiency reduced the overall phosphorylation of FceRI for both stimuli (14) . In contrast, phosphorylation of Syk on the activation loop tyrosines (Y519 and Y520), a marker of its activity, was reduced with 2NP treatment (fig. S4A) . The adapter molecule LAT1 (linker for activation of T cells-1) is a target of Syk and scaffolds multiple signaling molecules at the plasma membrane, including the phospholipases PLCg1 and PLCg2, whose activity is essential for initiating release of calcium from intracellular stores. Phosphorylation of LAT1 (Fig. 3B) and of PLCg1 and PLCg2 ( fig. S4B ) was greater in DNP-treated cells than in 2NP-treated cells. Calcium mobilization, a key regulator of degranulation (15), from intracellular or extracellular sources was also greater upon DNP treatment (Fig. 3C) , consistent with the better degranulation of DNP-treated cells relative to 2NP-treated cells. Phosphorylation of the LAT1-related adapter LAT2 was increased (Fig. 3B ) in 2NP-treated mast cells. Greater colocalization of LAT2 with FceRI was observed in 2NP-treated cells relative to DNP-treated cells (movies S3 and S4), and these differences (as determined by fluorescence intensity) were quantifiable (Fig.  3D) . Thus, the differences in FceRI clustering by DNP or 2NP alter the balance of molecular signaling, dampening some (i.e., LAT1 and PLCg phosphorylation) but enhancing others (i.e., LAT2 phosphorylation).
Although the absence of Lyn in mast cells caused decreased phosphorylation of FceRIg on Y47 (Fig. 3A) , phosphorylation at this site was greater in 2NP-treated cells relative to DNPtreated cells, which suggested the possible phosphorylation of FceRI by another tyrosine kinase after 2NP treatment. FceRI phosphorylation was completely inhibited by the Src family kinase selective inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrimidine (also known as AG1879 or PP2) ( fig. S5A) fig. S5C) . Reconstitution of these cells with a retrovirus encoding Hck also failed to restore phosphorylation of the aforementioned molecules. However, retroviral reconstitution with Fgr restored the phosphorylation of FceRI, LAT1, and LAT2, even in the absence of Lyn. Phosphorylation of LAT2 was increased relative to LAT1 ( fig. S5C ). Localization of FceRI with Fgr or Lyn in cells reconstituted with both proteins revealed increased colocalization of Fgr in 2NP-treated cells relative to DNP-treated cells but no significant change in Lyn colocalization with FceRI (movies S5 and S6). The amount of Fgr associated with FceRI (as determined by fluorescence intensity) in 2NP-treated cells was more than twice that in DNP-treated cells (Fig. 3E) . Thus, differences in FceRI clustering result in changes in the balance of receptor-associated kinases and subsequent downstream signaling. To determine whether Fgr or LAT2 contributed to the enhanced chemokine response observed after 2NP stimulation, we analyzed the chemokine (C-C motif ) ligand 2 (CCL2) response of Fgr-or LAT2-deficient mast cells after treatment with DNP or 2NP. Fgr or LAT2 deficiency impaired CCL2 secretion in response to both DNP and 2NP (Fig. 3F) . Conversely, overexpression of Fgr enhanced production of CCL2 in response to both DNP and 2NP (Fig. 3F) . Fgr or LAT2 deficiency enhanced 2NP-induced mast cell degranulation ( fig. S5D ), demonstrating negative regulatory control of this response.
Subtle changes in cell signaling may have consequences in vivo. To test this, we used a passive cutaneous anaphylaxis (PCA) model, which . Data are means T SE. **P < 0.01, ***P < 0.001; one-way ANOVA. One representative image of at least three independent experiments is shown for (B) and (C).
provides a localized assessment of mast cell responses, maintaining the factor of 100 times the 2NP concentration relative to that of DNP. At 30 min after exposure to DNP or 2NP, vascular permeability as measured by extravasation of Evans blue dye (see supplementary materials) was significantly higher in DNP-than 2NP-treated mice ( fig. S6A ). Consistent with this result, more mast cells were degranulated in animals treated with DNP. Ear swelling was significantly different 30 min after DNP or 2NP treatment but narrowed with time ( fig. S6B) , and the increase in the thickness of the dermis was similar at 3 hours after stimulation (fig. S6C ). Immune cell infiltration was similarly increased in animals exposed to DNP or 2NP ( fig. S6D) . By 12 hours after stimulation, the thickness of the dermis returned to that of control mice ( fig. S6E ) but immune cell infiltrates were still elevated relative to control mice ( fig. S6F ). Given that an inflammatory response was initiated by either DNP or 2NP, we explored the cell types involved. Gr-1 + CD11c -CD11b + cells were distinguished on the basis of the myeloid marker 7/4 [Ly-6B.2, which is somewhat more highly expressed by recently generated inflammatory macrophages (20) ] from neutrophils as marked by Ly-6G (Fig. 4A ). Exposure to DNP caused increased numbers of neutrophils relative to inflammatory macrophages, whereas this ratio was reversed in animals treated with 2NP, consistent with the increased secretion of monocyteor macrophage-attracting chemokines, such as CCL2, CCL3, and CCL4, after treatment of mast cells with 2NP (Fig. 1D) . Whole-mount immunohistochemical analysis of the skin also revealed these differences (Fig. 4 , B and C), and skin mast cells from 2NP-treated mice produced greater amounts of CCL2 than did those in the skin of DNP-treated mice ( fig. S7 ). Thus, low-affinity stimulation of FceRI results in an inflammatory response marked by a shift in the monocyte or macrophage/neutrophil ratio.
Collectively, our findings demonstrate that differences in the affinity of antigen and antibody interactions are discriminated by receptors through qualitative changes in molecular signals resulting in distinct outcomes. This discriminatory ability of receptors may extend beyond the immune system.
